ResMed Inc. Website

ResMed Inc.

NYSE-RMD

Basic

  • Market Cap

    $30.61B

  • EV

    $31.51B

  • Shares Out

    146.9M

  • Revenue

    $4,584.16M

  • Employees

    10,140

Margins

  • Gross

    56.51%

  • EBITDA

    31.44%

  • Operating

    28.12%

  • Pre-Tax

    25.83%

  • Net

    20.91%

  • FCF

    23.77%

Returns (5Yr Avg)

  • ROA

    13.42%

  • ROTA

    26.99%

  • ROE

    22.71%

  • ROCE

    22.22%

  • ROIC

    16.84%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $222.6

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $259.45M

  • Net Debt

    $908M

  • Debt/Equity

    0.25

  • EBIT/Interest

    23.55

Growth (CAGR)

  • Rev 3Yr

    14.04%

  • Rev 5Yr

    12.67%

  • Rev 10Yr

    11.42%

  • Dil EPS 3Yr

    27.6%

  • Dil EPS 5Yr

    16.04%

  • Dil EPS 10Yr

    11.05%

  • Rev Fwd 2Yr

    9.2%

  • EBITDA Fwd 2Yr

    15.33%

  • EPS Fwd 2Yr

    15.63%

  • EPS LT Growth Est

    13.31%

Dividends

  • Yield

    —

  • Payout

    28.85%

  • DPS

    $1.88

  • DPS Growth 3Yr

    6.42%

  • DPS Growth 5Yr

    4.9%

  • DPS Growth 10Yr

    7.41%

  • DPS Growth Fwd 2Yr

    9.34%

Select a metric from the list below to chart it

Jun '14

Jun '15

Jun '16

Jun '17

Jun '18

Jun '19

Jun '20

Jun '21

Jun '22

Jun '23

LTM

Jun '24 (E)

Jun '25 (E)

Jun '26 (E)

Metric
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
LTM

Total Revenues

2,606.6

2,957

3,196.8

3,578.1

4,223

4,584.2

Total Revenues % Chg.

11.4%

13.4%

8.1%

11.9%

18%

14.2%

Cost of Goods Sold, Total

1,070

1,189.6

1,307.4

1,514.2

1,836.9

1,993.6

Gross Profit

1,536.6

1,767.4

1,889.4

2,064

2,386.1

2,590.5

Selling General & Admin Expenses, Total

645

676.7

670.4

737.5

874

915.6

R&D Expenses

180.7

201.9

225.3

253.6

287.6

304.8

Amortization of Goodwill and Intangible Assets

74.9

79.7

76.2

70.7

72.4

80.9

Other Operating Expenses, Total

900.6

958.3

971.9

1,061.8

1,234.1

1,301.4

Operating Income

636

809.1

917.6

1,002.2

1,152

1,289.1

Interest Expense, Total

-36.2

-39.4

-23.6

-22.3

-47.4

-54.7

Interest And Investment Income

2.3

—

—

—

—

—

Net Interest Expenses

-33.9

-39.4

-23.6

-22.3

-47.4

-54.7

Income (Loss) On Equity Invest.

—

—

—

—

—

-15.8

-25.1

-11.2

-8.5

-7.3

-4.9

Currency Exchange Gains (Loss)

1.7

—

-0.8

2.8

-4.2

-4.2

Other Non Operating Income (Expenses)

2.6

2.4

1.1

0.4

-1.5

3.7

EBT, Excl. Unusual Items

590.6

747

883

974.5

1,091.6

1,229

Restructuring Charges

—

-9.4

—

-13.9

—

-9.2

-73.4

Merger & Related Restructuring Charges

—

—

—

—

-6.1

—

—

-1.9

-10.9

-1.8

Gain (Loss) On Sale Of Investments

—

—

-15

-14.5

14.5

-12.2

9.9

9.8

Insurance Settlements

—

—

—

—

—

—

—

—

—

20.2

20.2

Legal Settlements

—

—

—

—

-41.2

0.6

—

—

—

—

EBT, Incl. Unusual Items

518.8

733.1

883.7

960.5

1,101.7

1,183.9

Income Tax Expense

114.3

111.4

409.2

181

204.1

225.5

Earnings From Continuing Operations

404.6

621.7

474.5

779.4

897.6

958.4

Net Income

404.6

621.7

474.5

779.4

897.6

958.4

Net Income to Common Incl Extra Items

404.6

621.7

474.5

779.4

897.6

958.4

Net Income to Common Excl. Extra Items

404.6

621.7

474.5

779.4

897.6

958.4

Total Shares Outstanding

143.7

144.9

145.6

146.4

147.1

146.9

Weighted Avg. Shares Outstanding

143.1

144.3

145.3

146.1

146.8

147

Weighted Avg. Shares Outstanding Dil

144.5

145.7

146.5

147

147.5

147.6

EPS

2.8

4.3

3.3

5.3

6.1

6.5

EPS Diluted

2.8

4.3

3.2

5.3

6.1

6.5

EBITDA

752.9

922.9

1,029

1,126.2

1,292.1

1,441.4

Effective Tax Rate

22%

15.2%

46.3%

18.8%

18.5%

19%